JP2004505648A - 炎症関連ｇタンパク質共役受容体 - Google Patents

炎症関連ｇタンパク質共役受容体 Download PDF

Info

Publication number
JP2004505648A
JP2004505648A JP2002518985A JP2002518985A JP2004505648A JP 2004505648 A JP2004505648 A JP 2004505648A JP 2002518985 A JP2002518985 A JP 2002518985A JP 2002518985 A JP2002518985 A JP 2002518985A JP 2004505648 A JP2004505648 A JP 2004505648A
Authority
JP
Japan
Prior art keywords
polynucleotide
seq
polypeptide
specified
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002518985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505648A5 (2
Inventor
ガボール・ヤライ
シダ・ユーセフィ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of JP2004505648A publication Critical patent/JP2004505648A/ja
Publication of JP2004505648A5 publication Critical patent/JP2004505648A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2002518985A 2000-08-18 2001-08-16 炎症関連ｇタンパク質共役受容体 Pending JP2004505648A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64165300A 2000-08-18 2000-08-18
PCT/EP2001/009466 WO2002013845A2 (en) 2000-08-18 2001-08-16 Inflammation related g-protein coupled receptor

Publications (2)

Publication Number Publication Date
JP2004505648A true JP2004505648A (ja) 2004-02-26
JP2004505648A5 JP2004505648A5 (2) 2008-10-02

Family

ID=24573290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002518985A Pending JP2004505648A (ja) 2000-08-18 2001-08-16 炎症関連ｇタンパク質共役受容体

Country Status (4)

Country Link
EP (1) EP1364017A2 (2)
JP (1) JP2004505648A (2)
AU (1) AU2002212140A1 (2)
WO (1) WO2002013845A2 (2)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
US6902902B2 (en) 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
US7189524B1 (en) 2002-11-25 2007-03-13 Amgen, Inc. Receptor ligands and methods of modulating receptors
EP1597587A2 (en) 2003-02-17 2005-11-23 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a)
WO2004083388A2 (en) 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
WO2006021892A2 (en) * 2004-08-27 2006-03-02 Endocube S.A.S. Hm74 and hm74a in cuboidal endothelial cells as associated with inflammation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056820A1 (en) * 1997-06-12 1998-12-17 Smithkline Beecham Corporation Hm74a receptor
WO2000022129A1 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056820A1 (en) * 1997-06-12 1998-12-17 Smithkline Beecham Corporation Hm74a receptor
WO2000022129A1 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors

Also Published As

Publication number Publication date
WO2002013845A3 (en) 2003-07-10
AU2002212140A1 (en) 2002-02-25
WO2002013845A2 (en) 2002-02-21
EP1364017A2 (en) 2003-11-26

Similar Documents

Publication Publication Date Title
US20020187947A1 (en) Inflammation-related gene
US20020015950A1 (en) Atherosclerosis-associated genes
JP2002521055A (ja) ９８個のヒト分泌タンパク質
JP2003508088A (ja) ５２個のヒト分泌タンパク質
US20040152161A1 (en) Hematopoietin receptor
US20080009004A1 (en) Claudin polypeptides, polynucleotides, and methods of making and use thereof
JP2004505648A (ja) 炎症関連ｇタンパク質共役受容体
WO2001019986A1 (fr) Recepteur d'un leucotriene peptidique
JP2003525634A (ja) Ｆｃｔｒｘと命名されたタンパク質およびこれをコードする核酸
US20030078218A1 (en) Inflammation related G-protein coupled receptor
US20040048304A1 (en) 95 human secreted proteins
JP2003510028A (ja) ２５個のヒト分泌タンパク質
JP2003503014A (ja) ７回膜貫通レセプター遺伝子
JP2002534088A (ja) インスリン合成遺伝子
US6444443B1 (en) Gene
US7105315B2 (en) Transmembrane protein differentially expressed in cancer
JP2003510074A (ja) ２６個のヒト分泌タンパク質
JP2004516813A (ja) 関連腫瘍マーカー
US20020099017A1 (en) Novel gene
WO1999067383A1 (fr) Nouvelle proteine receptrice couplee a la proteine g, adn correspondante et leur utilisation
JP2002543762A (ja) ヒトｃｌａｘタンパク質およびその可溶性融合タンパク質をコードするｄｎａ分子
JP2000152792A (ja) 新規ｇ蛋白質共役型受容体蛋白質、ｄｎａおよびその用途
JP2002539785A (ja) ５０個のヒト分泌タンパク質
JP2000236882A (ja) マウスナース細胞レセプター遺伝子
JP2000308492A (ja) ヒトナース細胞レセプター遺伝子

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080812

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080812

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110201

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110913